Skip to main content

Advertisement

Log in

Type 2 Diabetes Mellitus Remission Models Following Laparoscopic Gastric Bypass: a 4-Model Analysis in a Latino Population

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Bariatric surgery is indicated for major weight loss and for the control of associated comorbidities, particularly type 2 diabetes. Remission prediction scores have been proposed for this end, such as: DiaRem, Ad-DiaRem, ABCD, and DiaBetter. Nevertheless, they have not been evaluated all together in a specific population.

Methods

Retrospective study with Mexican patients submitted to gastric bypass with at least 12 months follow-up. All patients had BMI > 30 kg/m2 and type 2 diabetes. The primary objective was to evaluate the remission prediction performance of scores. A baseline analysis (anthropometric, biochemical, and metabolic) and remission rates were obtained. Remission scores and cut-off values were assigned based on original descriptions. A ROC analysis was performed for sensibility and specificity.

Results

A total of 95 patients were included. Mean age 44 years, 85.6% female with mean BMI of 44.1 kg/m2, and mean HbA1C of 7.2%. At 12 months, complete remission was obtained in 76.8%. ROC curves were plotted showing that DiaRem had 75.3% sensitivity and 68.2% specificity (AUC 0.723 p = 0.001), Ad-DiaRem had 84.9% and 50% (AUC 0.702 p = 0.002), ABCD had 57.5% and 77.3% (AUC 0.0.690 p = 0.002), and DiaBetter had 72.6% and 77.3% (AUC 0.748 p < 0.001).

Conclusion

In Mexican patients with obesity and type 2 Diabetes, submitted to gastric bypass, remission prediction could be assessed with any current model showing satisfactory sensibility and specificity. Among such models, DiaBetter obtained the best statistical performance in our population. Type 2 diabetes remission rate at 1 year is similar to any other race or ethnicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Leitner DR, Frühbeck G, Yumuk V, et al. Obesity and type 2 diabetes: two diseases with a need for combined treatment strategies - EASO can lead the way. Obes Facts. 2017;10:483–92. https://doi.org/10.1159/000480525.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mandviwala T, Khalid U, Deswal A. Obesity and cardiovascular disease: a risk factor or a risk marker? Curr Atheroscler Rep. 2016;18 https://doi.org/10.1007/s11883-016-0575-4.

  3. Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2004;110:2952–67. https://doi.org/10.1161/01.CIR.0000145546.97738.1E.

    Article  PubMed  Google Scholar 

  4. Verma S, Hussain ME. Obesity and diabetes: an update. Diabetes Metab Syndr Clin Res Rev. 2017;11:73–9. https://doi.org/10.1016/j.dsx.2016.06.017.

    Article  Google Scholar 

  5. Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14:160–9. https://doi.org/10.1038/nrgastro.2016.170.

    Article  PubMed  Google Scholar 

  6. Bray GA, Frühbeck G, Ryan DH, et al. Management of obesity. Lancet. 2016;387:1947–56. https://doi.org/10.1016/S0140-6736(16)00271-3.

    Article  PubMed  Google Scholar 

  7. Shah A, Laferrère B. Diabetes after bariatric surgery. Can J Diabetes. 2017;41:401–6. https://doi.org/10.1016/j.jcjd.2016.12.009.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Still CD, Wood GC, Benotti P, et al. A probability score for preoperative prediction of type 2 diabetes remission following RYGB surgery. Lancet Diabetes Endocrinol. 2014;2:38–45. https://doi.org/10.1016/S2213-8587(13)70070-6.A.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Aron-Wisnewsky J, Sokolovska N, Liu Y, et al. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass. Diabetologia. 2017;60:1892–902. https://doi.org/10.1007/s00125-017-4371-7.

    Article  PubMed  Google Scholar 

  10. Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013;9:379–84. https://doi.org/10.1016/j.soard.2012.07.015.

    Article  PubMed  Google Scholar 

  11. Pucci A, Tymoszuk U, Cheung WH, et al. Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabet Med. 2018;35:360–7. https://doi.org/10.1111/dme.13532.

    Article  CAS  PubMed  Google Scholar 

  12. Zhang R, Borisenko O, Telegina I, et al. Systematic review of risk prediction models for diabetes after bariatric surgery. Br J Surg. 2016;103:1420–7. https://doi.org/10.1002/bjs.10255.

    Article  CAS  PubMed  Google Scholar 

  13. Alegre-Díaz J, Herrington W, López-Cervantes M, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016;375:1961–71. https://doi.org/10.1056/NEJMoa1605368.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5. https://doi.org/10.2337/dc09-9036.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zerrweck-Lopez C. Origen del “bypass gastrico simplificado.” Cir y Cir (English Ed 2015;83:87–8. https://doi.org/10.1016/j.circir.2015.04.030.

  16. Espinosa O, Pineda O, Maydón HG, et al. Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m 2 using strict remission criteria: early outcomes of a prospective study among Mexicans. Surg Endosc. 2018;32:1353–9. https://doi.org/10.1007/s00464-017-5815-3.

    Article  PubMed  Google Scholar 

  17. Aminian A, Brethauer SA, Andalib A, et al. Individualized metabolic surgery score: procedure selection based on diabetes severity. Ann Surg. 2017;266:650–7. https://doi.org/10.1097/SLA.0000000000002407.

    Article  PubMed  Google Scholar 

  18. Cohen RV, Shikora S, Petry T, et al. The diabetes surgery summit II guidelines: a disease-based clinical recommendation. Obes Surg. 2016;26:1989–91. https://doi.org/10.1007/s11695-016-2237-6.

    Article  PubMed  Google Scholar 

  19. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–256.e5. https://doi.org/10.1016/j.amjmed.2008.09.041.

    Article  PubMed  Google Scholar 

  20. Ng J, Seip R, Stone A, et al. Ethnic variation in weight loss, but not co-morbidity remission, after laparoscopic gastric banding and Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015;11:94–100. https://doi.org/10.1016/j.soard.2014.07.013.

    Article  PubMed  Google Scholar 

  21. Kodama S, Fujihara K, Horikawa C, et al. Network meta-analysis of the relative efficacy of bariatric surgeries for diabetes remission. Obes Rev. 2018;19:1621–9. https://doi.org/10.1111/obr.12751.

    Article  CAS  PubMed  Google Scholar 

  22. Zorrilla-Nunez LF, Campbell A, Giambartolomei G, et al. The importance of the biliopancreatic limb length in gastric bypass: a systematic review. Surg Obes Relat Dis. 2019;15:43–9. https://doi.org/10.1016/j.soard.2018.10.013.

    Article  PubMed  Google Scholar 

  23. Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Obes Surg. 2017;27:2–21. https://doi.org/10.1007/s11695-016-2457-9.

    Article  PubMed  Google Scholar 

  24. Madadi F, Jawad R, Mousati I, et al. Remission of type 2 diabetes and sleeve gastrectomy in morbid obesity: a comparative systematic review and meta-analysis. Obes Surg. 2019;29:4066–76. https://doi.org/10.1007/s11695-019-04199-3.

    Article  PubMed  Google Scholar 

  25. Borgeraas H, Hofsø D, Hertel JK, et al. Comparison of the effect of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2020;21:1–11. https://doi.org/10.1111/obr.13011.

    Article  Google Scholar 

  26. Dicker D, Golan R, Aron-Wisnewsky J, et al. Prediction of long-term diabetes remission after RYGB, sleeve gastrectomy, and adjustable gastric banding using DiaRem and advanced-DiaRem scores. Obes Surg. 2019;29:796–804. https://doi.org/10.1007/s11695-018-3583-3.

    Article  PubMed  Google Scholar 

  27. Wong RJ, Chou C, Sinha SR, et al. Ethnic disparities in the association of body mass index with the risk of hypertension and diabetes. J Community Health. 2014;39:437–45. https://doi.org/10.1007/s10900-013-9792-8.

    Article  PubMed  Google Scholar 

  28. Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology. Surg Obes Relat Dis. 2019;16:175–247. https://doi.org/10.1016/j.soard.2019.10.025.

    Article  PubMed  Google Scholar 

  29. Ramírez EM, Espinosa O, Berrones R, et al. The impact of preoperative BMI (obesity class I, II, and III) on the 12-month evolution of patients undergoing laparoscopic gastric bypass. Obes Surg. 2018;28:3095–101. https://doi.org/10.1007/s11695-018-3281-1.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlos Zerrweck.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This retrospective analysis was approved by the local research and ethics committees (Institutional Register 212-110-11-19) and registered at the national committees (CONBIOÉTICA-09-CEI-001-20160404).

Informed Consent

For this type of study, formal consent is not required. Every patient signed an informed consent for the surgery.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendices

Appendix 1

Table 4 Items used in T2DM remission scores

Appendix 2

Table 5 Items used in the diabetes remission scores
Table 6 Diabetes remission models and remission among Mexicans. Stratification of the obtained scores by patient/group and comparison of the obtained remission rates according to the original description

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herrera, A., León, A., Rodríguez, F.M. et al. Type 2 Diabetes Mellitus Remission Models Following Laparoscopic Gastric Bypass: a 4-Model Analysis in a Latino Population. OBES SURG 31, 544–553 (2021). https://doi.org/10.1007/s11695-020-04920-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-020-04920-7

Keywords

Navigation